BioStem Technologies annual gross margin
2021
2022
2023
2024
2025
BioStem Technologies Gross Margin Growth & History (BSEM)
BioStem Technologies's gross margin was 93.59% for fiscal 2025.
View full BioStem Technologies company overviewBioStem Technologies annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 93.59% | +13.32 pp |
| 2024 | 2024-12-31 | 80.27% | −12.17 pp |
| 2023 | 2023-12-31 | 92.45% | +5.27 pp |
| 2022 | 2022-12-31 | 87.17% | +21.15 pp |
| 2021 | 2021-12-31 | 66.03% | — |
BioStem Technologies quarterly gross margin
Q4.24
Q1.25
Q2.25
Q3.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 61.28% | −32.47 pp |
| Q1 2026 | 2026-03-31 | 60.05% | −18.88 pp |
| Q3 2025 | 2025-09-30 | 88.50% | — |
| Q2 2025 | 2025-06-30 | 93.75% | — |
| Q1 2025 | 2025-03-31 | 78.94% | — |
| Q4 2024 | 2024-12-31 | 96.56% | — |
BioStem Technologies gross margin trends
Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's gross margin increased from 66.03% to 93.59%, a change of +27.57 percentage points. The latest reported quarter, Q2 2026, shows 61.28%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioStem Technologies source filings ↗